Ligands for the isolation of GABA(B) receptors [corrected] .
Since the discovery that the most abundant inhibitory neurotransmitter in the mammalian brain, GABA (gamma-aminobutyric acid), interacts not only with ionotropic GABA(A) receptors, but also with metabotropic GABA(B) receptors (Bowery et al., 1980) much work has been devoted to the elucidation of the structure of GABA(B) receptors by either affinity chromatography purification or by expression cloning. In 1997 Kaupmann et al. succeeded in cloning two splice variants designated GABA(B) R1a (960 amino acids) and GABA(B) R1b (844 amino acids). Although the amino acid sequences are now known, precise information on the three-dimensional environment of the GABA(B) R1 binding site is still lacking. Recent experiments demonstrated that the amino acids of the seven transmembrane helices are not essential for ligand binding as a soluble GABA(B) receptor fragment is still able to bind antagonists (Malitschek et al., 1999). For the isolation and purification of the soluble N-terminal extracellular domain (NTED) of GABA(B) receptors potent ligands for affinity chromatography were synthesised with the aim of obtaining a crystalline receptor fragment-ligand complex for X-ray structure determination. The most promising ligand [125I]CGP84963 (K(D) = 2 nM) combines, in one molecule, a GABA(B) receptor binding part, an azidosalicylic acid as a photoaffinity moiety separated by a spacer consisting of three GABA molecules from 2-iminobiotin, which binds to avidin in a reversible, pH-dependent fashion.
Froestl
W
W
Novartis Pharma AG, Therapeutic Area Nervous System, Basel, Switzerland. wolfgang.froestl@pharma.novartis.com
Bettler
B
B
Bittiger
H
H
Heid
J
J
Kaupmann
K
K
Mickel
S J
SJ
Strub
D
D
D000818:Animals; D001565:Benzoates / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism; D002846:Chromatography, Affinity; D018756:GABA Antagonists / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D008024:Ligands; D009943:Organophosphorus Compounds / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D051381:Rats; D018080:Receptors, GABA-B / Q000737:chemistry / Q000378:metabolism*
D001565:Benzoates; C104981:CGP 64213; D018756:GABA Antagonists; D008024:Ligands; D009943:Organophosphorus Compounds; D018080:Receptors, GABA-B